Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

expanding labels, and advancing late-stage assets," alluding to the new Kerendia and Nubeqa trials, as well as new menopause symptom treatment elinzanetant and acoramidis for ATTR cardiomyopathy ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most were in favor of the change and agreed that, if finalized ...

New labels will soon alert consumers to information already on the back of food packaging about low, medium or high levels of sodium, added sugars and saturated fat. The FDA believes this ...

Zoetis (ZTS) announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement ...

As per its FDA label, Ozempic is also indicated to reduce the risk of major adverse cardiovascular events in adults with T2D and established heart disease. Novo Nordisk is eyeing up further ...

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Stallergenes Greer’s peanut allergy treatment Palforzia scored a label expansion in Europe, extending the drug’s use to toddlers aged 1 through 3 years old. Palforzia is now cleared for use in ...